350The Guide to Entrepreneurship: How to Create Wealth for Your Company
15.7 Mergers and Acquisitions
Mergers and acquisitions (abbreviated M&A) is an aspect of corporate
strategy, corporate nance and management dealing with the buying, sell-
ing, dividing, and combining of different companies and similar entities that
can help an enterprise grow rapidly in its sector or location of origin, or a
new eld or new location, without creating a subsidiary, other child entity,
or using a joint venture.
5
15.7.1 Mergers
Theoretically, a merger happens when two rms agree to go forward as
a single new company rather than remain separately owned and operated.
This kind of action is more precisely referred to as a “merger of equals.
In practice, however, actual mergers of equals do not happen very often.
Usually, one company will buy another and, as part of the deals terms, sim-
ply allow the acquired rm to proclaim that the action is a merger of equals,
even if it is technically an acquisition.
6
15.7.2 Acquisitions
Practically speaking, an acquisition is the process through which one com-
pany completely takes over the controlling interest of another company. Such
Post
Merger
integration
Seller
decision
to sell
Buyer’s
strategy
Negotiations +
Valuation
Offer
Acceptance
Consideration
Closing
Legal, tax
Acc’t
Finance
Management
Sales
Marketing
Market
impact
M&A process at a glance
Figure 15.9 M&A process at a glanceVisual representation of the M&A process
from start of negotiations to post-closing activities.
Harvesting351
controlling interest may be 100%, or nearly 100%, of the assets or ownership
equity of the acquired entity. An “acquisition” usually refers to a purchase of
a smaller rm by a larger one (Figure15.10).
There are two sets of stockholders affected by a merger or acquisition:
those of the rm being acquired and those of the rm doing the acquiring.
15.7.3 The Challenge of M&A
There are many examples of successful M&A (and many more failures).
The most spectacular M&A failure of all times was the acquisition of Time
Warner by AOL. In January 2000, America Online merged with Time Warner
in a deal valued at a stunning $350 billion. It was then, and is now, the larg-
est merger (and eventual de-merger) in American business history.
Due to the larger market capitalization of AOL, they would own 55% of
the new company while Time Warner shareholders owned only 45%. So in
actual practice AOL had acquired Time Warner, even though AOL had far
less assets and revenues.
7
What was the perception of the average stockholder when AOL offered
such a large premium over market price to purchase Time Warner? The aver-
age AOL stockholder wondered whether the acquisition was being made in
their interest or in the interest of management. Some important lessons have
M/A Occur in Waves
Monopolies
2.5%
2.0%
1.5%
1.0%
0.5%
0.0%
1926
1930
1935
1940
1945
1949
1954
1959
1964
Quarters
Percentage of All Public Companies
1968
1973
1978
1983
1987
1992
1997
2002
2005
60s
conglomerate
deals
80s hostile
takeovers
2000s global,
synergistic
Figure 15.10 M/A occur in wavesDue to economic/regulatory changes, M/A activ-
ity occurs in waves.
352The Guide to Entrepreneurship: How to Create Wealth for Your Company
been learned from the AOL/Time Warner failure. The following ve criteria
have been offered as success principles for M&A/strategic alliances:
8
Compatible strategy and culture
No overpayment
Comparable contribution
Compatible strengths
No conict of interest
So, what is an M&A success and what is an M&A failure? Is it a matter of
luck, perception, or timing? The author recommends a quantitative measure,
based on Return on Invested Capital (ROIC) and Weighted Average Cost of
Capital (WACC) as shown next:
Failure ROIC < WACC
Success ROIC > WACC
where
ROIC = earnings before interest and taxes divided by (invested capital
equity + long-term liabilities)
WACC = Sum of after-tax of debt and equity, multiplied by their respec-
tive percentage of capital structure
15.7.4 The Enduring Questions
Prior to consummation of the transaction, the buyer and the seller nd
themselves in an adversarial position. Table15.4 lists the ten most frequently
asked questions in buying or selling a business. Paradoxically, although the
questions look similar, the answers are not.
15.8 The Day That Little David Acquired
Giant GoliathA Case Study
When academicians talk about acquisitions, they are usually referencing
events such as: “Johnson & Johnson acquires Company X for billions,” or
Apple Inc. acquires Company Y for billions.” Seldom do small companies
undertake acquisitions as part of a well-reasoned strategy for growth even
mentioned in the literature or the classroom. Following is the story of an
acquisition by a small company called CardioTech.
By 2002, CardioTech (a company founded by Dr. Michael Szycher and
publically traded in the AMEX), had decided to grow inorganically by
Harvesting353
opportunistically pursuing an accretive acquisition strategy. To reduce any
managerial impulsive and emotional decisions, CardioTech pre-established a
systematic, quantitative acquisition criteria matrix, as shown in the following:
Balance Sheet Criteria
Debt-to-equity ratio
Working capital
Liquidity requirements
Performance Criteria
Return on equity
Return on invested capital
Return on assets
Earnings growth rates
Business Characteristics Criteria
Relative market position
Market share
Competitive strengths
Product line
Table15.4 The Most Frequently Asked Questions by Sellers and Buyers
Seller Buyer
Why is their offering price so low? Why is their asking price so high?
Are they bottom shing? Are they serious about selling?
Is it okay for us to shop around? Should this be a no-shop negotiations?
Why are they interested in us? What do we really know about them?
Do we really need money now?
Is this transaction for cash or shares?
What will they do with our money?
What are their future nancial demands?
Who should be part of our negotiation
team?
Are we really negotiating with the
decision makers?
How much independence do we retain
post-transaction?
How do we integrate them into our
winning culture?
Could we do better on our own? Do we really need them?
What happens if the deal collapses?
How vulnerable do we remain?
What if we nd deal-killers during due
diligence?
What happens if our CEO is run over by
the mythical train during negotiations?
How indispensable is their CEO?
Do they have a succession strategy?
354The Guide to Entrepreneurship: How to Create Wealth for Your Company
Cash generation
Price and cost structure
Geographical reach
Market/Industry Characteristics Criteria
Barriers to entry
Governmental regulations
Industry growth
Company growth cycle
Investment Criteria
Quality of earnings
History of labor relations
Labor intensive or technology intensive
Intellectual property portfolio
This case study exemplies the unusual occurrence when CardioTech
(little David with $3 million in sales) acquired Gish Biomedical (giant
Goliath with $17 million in sales). Please note this was not a merger;
it was an acquisition. At the end of the transaction, CardioTech owned
100% of Gish. That is, Gish became an operating, fully owned subsidiary
of CardioTech.
After establishing the above criteria for the acquisition, CardioTech started
the search for an appropriate target. The following paragraphs enumerate
the history behind the acquisition.
15.8.1 The Acquisition
On April7, 2003, CardioTech completed the acquisition of Gish Biomedical.
Gish shareholders were issued 1.3422shares of CardioTech stock for each of
their shares of Gish common stock. Gish Biomedical,Inc., a California corpo-
ration, was founded in 1976 to design, produce, and market innovative spe-
cialty surgical devices. Gish developed and marketed its innovative and unique
devices for various applications within the medical community. Gish operated
in the medical devices segment—the manufacture of medical devices—which
were marketed through direct sales representatives and distributors domesti-
cally and through international distributors. All of Gishs products were sin-
gle-use disposable products or had a disposable component. Gishs primary
markets included products for use in cardiopulmonary bypass surgery, myo-
cardial management, infusion therapy, and postoperative blood salvage.
Prior to the transaction, Gish had been experiencing a steady 10% decline
in annual sales for the previous 5 years. This followed the overall downward
..................Content has been hidden....................

You can't read the all page of ebook, please click here login for view all page.
Reset
18.223.195.29